Jingfang Cheng

Risk factors for breast cancer from benign breast disease in a diverse population

A. Kapke, M. Worsham, U. Raju, 2009, Breast Cancer Research and Treatment.

Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer.

T. DeWeese, J. Peabody, B. Movsas, 2014, International journal of radiation oncology, biology, physics.

Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer.

B. Movsas, K. Barton, H. Stricker, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Benign breast disease heterogeneity: association with histopathology, age, and ethnicity

S. Qiu, M. Worsham, U. Raju, 2007, Breast Cancer Research and Treatment.

Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer

B. Movsas, M. Ajlouni, K. Barton, 2020, Molecular therapy oncolytics.

Breast Cancer Incidence in a Cohort of Women with Benign Breast Disease from a Multiethnic, Primary Health Care Population

Judith Abrams, A. Kapke, J. Abrams, 2007, The breast journal.

Acute Recurrent Pancreatitis; Relative Risk Factors, Etiology ,Diagnosis Procedure And Treatment In the Pancreatic disease Institute of Wuhan Union Hospital Of China

Zhi-Yong Wang, Heshui Wu, Chun-you Wang, 2015 .

Multiplicity of Benign Breast Lesions Is a Risk Factor for Progression to Breast Cancer

A. Kapke, M. Worsham, U. Raju, 2007, Clinical Cancer Research.